Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History COLL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics COLL

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Collegium Pharmaceutical Inc

COLL
Current price
30.35 USD -0.16 USD (-0.52%)
Last closed 30.51 USD
ISIN US19459J1043
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 975 515 776 USD
Yield for 12 month -4.86 %
1Y
3Y
5Y
10Y
15Y
COLL
21.11.2021 - 28.11.2021

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. Address: 100 Technology Center Drive, Stoughton, MA, United States, 02072

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

41.25 USD

P/E Ratio

24.88

Dividend Yield

Financials COLL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures COLL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+631 449 000 USD

Last Year

+566 767 000 USD

Current Quarter

+177 757 000 USD

Last Quarter

+181 949 000 USD

Current Year

+377 344 000 USD

Last Year

+326 169 000 USD

Current Quarter

+97 324 000 USD

Last Quarter

+98 288 000 USD
EBITDA 364 824 000 USD
Operating Margin TTM 13.71 %
Price to Earnings 24.88
Return On Assets TTM 7.95 %
PEG Ratio
Return On Equity TTM 19.23 %
Wall Street Target Price 41.25 USD
Revenue TTM 664 283 008 USD
Book Value 7.30 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 22.70 %
Dividend Yield
Gross Profit TTM 578 217 984 USD
Earnings per share 1.22 USD
Diluted Eps TTM 1.22 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -90.10 %
Profit Margin 6.61 %

Stock Valuation COLL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 24.88
Forward PE 4.44
Enterprise Value Revenue 2.44
Price Sales TTM 1.47
Enterprise Value EBITDA 4.87
Price Book MRQ 4.16

Technical Indicators COLL

For 52 Weeks

23.23 USD 42.29 USD
50 Day MA 29.02 USD
Shares Short Prior Month 4 904 665
200 Day MA 31.15 USD
Short Ratio 17.76
Shares Short 4 816 415
Short Percent 17.88 %